Sandbox:SMMM: Difference between revisions
Jump to navigation
Jump to search
(8 intermediate revisions by 2 users not shown) | |||
Line 27: | Line 27: | ||
Shown below is an algorithm summarizing the diagnosis of disease name according the Endocrine Society Clinical Practice guideline. | Shown below is an algorithm summarizing the diagnosis of disease name according the Endocrine Society Clinical Practice guideline. | ||
{{familytree/start |summary=PE diagnosis Algorithm.}} | {{familytree/start |summary=PE diagnosis Algorithm.}} | ||
{{Family tree | | | | A01 | | | |A01= Initial evaluation & diagnosis of hirsutism}} | {{Family tree | | | | | A01 | | | |A01= Initial evaluation & diagnosis of hirsutism}} | ||
{{Family tree | | | | |!| | | | | }} | {{Family tree | | | | | |!| | | | | }} | ||
{{Family tree | | | | B01 | | | |B01= History & physical examination including pelvic examination}} | {{Family tree | | | | | B01 | | | |B01= History & physical examination including pelvic examination}} | ||
{{Family tree | | | | |!| | | | | }} | {{Family tree | | | | | |!| | | | | }} | ||
{{family tree | | | | C01 |-|-|-| C02 | | | | | |C01= Medication use? *Ask for anabolic or androgenic steroids (in athletes, patients who are using dietary supplements, patients with sexual dysfunction, or in patients with a partner who uses testosterone gel) and valproic acid (in patient with neurologic disorders|C02= Discontinue medication }} | {{family tree | | | | | C01 |-|-|-| C02 | | | | | |C01= Medication use? *Ask for anabolic or androgenic steroids (in athletes, patients who are using dietary supplements, patients with sexual dysfunction, or in patients with a partner who uses testosterone gel) and valproic acid (in patient with neurologic disorders|C02= Discontinue medication }} | ||
{{Family tree | | | | |!| | | | | }} | {{Family tree | | | | | |!| | | | | }} | ||
{{family tree | | | | D01 |-|-|-| D02 | | | | | |D01= Isolated local hair growth| D02= Direct hair removal methods}} | {{family tree | | | | | D01 |-|-|-| D02 |-|-|-|D03 |-|-|-|D04|D01= Isolated local hair growth| D02= Direct hair removal methods| D03= Improvement or stable| D04= Normal variant | ||
}} | |||
{{Family tree | | | | | |!| | | | | |!| | | |}} | |||
{{Family tree | | | | | E01 | | | | |!| | | |E01= Abnormal hirsutism score or local hair growth with symptoms suggesting hyperandrogenic endocrine disorder*? *menstrual irregularity, infertility, galactorrhea, signs or symptoms of hypothyroidism, Cushing syndrome, acromegaly, central obesity,acanthosis nigricans, clitoromegaly, or sudden-onset or rapid-progression hirsutism suggests the presence of a hyperandrogenic endocrine disorder}} | |||
{{Family tree | | | | | |!| | | | | |!| | | |}} | |||
{{Family tree | | | | | F01 |-|-|-| F02| | | |F01= Early morning total testosterone blood level| F02= Progression or unstable}} | |||
{{Family tree | | | |,|-|^|-|-|-|-|-|.| | | }} | |||
{{Family tree | | |G01| | | | | |G02| | | |G01= Normal| G02= Elevated}} | |||
{{Family tree | |,|-|^|-|-|.| | | | |!| }} | |||
{{Family tree | |H01| | |H02| | |!||H01= Mild isolated hirsutism|H02= Moderate to severe hirsutism or presence of hyperandrogenic endocrine disorder}} | |||
{{Family tree | | |!| | | |!| | | | |!| }} | |||
{{Family tree | |I01| | |!| | | | |!| I01= Direct hair removal methods or oral contraceptive}} | |||
{{Family tree | | |!| | | |!| | | | |!|}} | |||
{{Family tree | | |!| | |J01| | |J02| | | | |J01= |J02=<div style="float: left; text-align: left; height: 16em; width: 19em; padding:1em;"> }} | |||
{{Family tree | |,|^|-|-|.| |}} | |||
{{Family tree | |K01| |K02| | | |K01= |K02= }}} | |||
{{familytree/end}} |
Latest revision as of 17:59, 19 August 2020
S.Mojdeh Mirmomen
Treatment
Shown below is an algorithm summarizing the treatment of hirsutism according the Endocrine Society Clinical Practice guidelines.
Initial therapy for patient with hirsutism | |||||||||||||||||||||||||||||||||||||||
Mild hirsutism and no evidence of an endocrine disorder | Moderate or patient-important hirsutism | Severe hirsutism | |||||||||||||||||||||||||||||||||||||
Direct hair removal methods | Pharmacological therapy | Pharmacological therapy (add direct hair removal if needed) | Combined pharmacological therapy | ||||||||||||||||||||||||||||||||||||
• Photoepilation for women with auburn, brown, or black unwanted hair • Electrolysis for women with white or blonde hair | • Start oral contraceptives in women who are not seeking fertility ** Use oral contraceptives containing the lowest effective dose of ethinyl estradiol and a low-risk progestin for women at higher risk for venous thromboembolism (e.g., obese or >39 years old) • Start either oral contraceptives or anti-androgens in women who are not sexually active, have undergone permanent sterilization, or who are using long-acting reversible contraception | Oral contraceptives and antiandrogens | |||||||||||||||||||||||||||||||||||||
Add an antiandrogen if hirsutism remains despite 6 months of monotherapy with an oral contraceptive | |||||||||||||||||||||||||||||||||||||||
Diagnosis
Shown below is an algorithm summarizing the diagnosis of disease name according the Endocrine Society Clinical Practice guideline.
}Initial evaluation & diagnosis of hirsutism | |||||||||||||||||||||||||||||||||||||||||||||||||
History & physical examination including pelvic examination | |||||||||||||||||||||||||||||||||||||||||||||||||
Medication use? *Ask for anabolic or androgenic steroids (in athletes, patients who are using dietary supplements, patients with sexual dysfunction, or in patients with a partner who uses testosterone gel) and valproic acid (in patient with neurologic disorders | Discontinue medication | ||||||||||||||||||||||||||||||||||||||||||||||||
Isolated local hair growth | Direct hair removal methods | Improvement or stable | Normal variant | ||||||||||||||||||||||||||||||||||||||||||||||
Abnormal hirsutism score or local hair growth with symptoms suggesting hyperandrogenic endocrine disorder*? *menstrual irregularity, infertility, galactorrhea, signs or symptoms of hypothyroidism, Cushing syndrome, acromegaly, central obesity,acanthosis nigricans, clitoromegaly, or sudden-onset or rapid-progression hirsutism suggests the presence of a hyperandrogenic endocrine disorder | |||||||||||||||||||||||||||||||||||||||||||||||||
Early morning total testosterone blood level | Progression or unstable | ||||||||||||||||||||||||||||||||||||||||||||||||
Normal | Elevated | ||||||||||||||||||||||||||||||||||||||||||||||||
Mild isolated hirsutism | Moderate to severe hirsutism or presence of hyperandrogenic endocrine disorder | ||||||||||||||||||||||||||||||||||||||||||||||||
Direct hair removal methods or oral contraceptive | |||||||||||||||||||||||||||||||||||||||||||||||||